Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.

Monthly MRD monitoring by ddPCR in her bone marrow samples showed a decreasing trend to < 0.1%, concordant with the weakly positive nested conventional PCR results, albeit flow cytometry gave undetectable MRD results but at a lower analytical sensitivity validated to 0.1%.

also in 47,180 other papers